Other substances

Idarubicin

An anthracycline antineoplastic drug.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Used to treat other disease

1
 Supporting references
0
 Contradictory references
1
 AI-suggested references
0
 Clinical trials

General information

Idarubicin on PubChem

Synonyms

4-Demethoxydaunorubicin

Marketed as

IDAMYCIN

 

Structure image - Idarubicin

C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O

Supporting references

Link Tested on Impact factor Notes Publication date
Evaluation of potential anti-RNA-dependent RNA polymerase (RdRP) drugs against the newly emerged model of COVID-19 RdRP using computational methods
RdRpol Small molecule In silico 		in silico 2.00

Predicted to inhibit SARS-CoV-2 RNA-dependent RNA polymerase.

 Feb/20/2021

AI-suggested references

Link Publication date
Identification of potential inhibitors of SARS-COV-2 endoribonuclease (EndoU) from FDA approved drugs: a drug repurposing approach to find therapeutics for COVID-19
Jun/09/2020
Export (.csv)